SIMILAR PATTERNS OF AMINO ACIDS FOR 3TGV_C_BEZC1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1a59 CITRATE SYNTHASE

(Antarctic
bacterium
DS2-3R) 		PF00285
(Citrate_synt) 		4 TYR A 321
PHE A 232
PRO A 325
LEU A 301
 None
 1.34A 3tgvC-1a59A:
0.0		 3tgvC-1a59A:
17.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bnl COLLAGEN XVIII

(Homo sapiens) 		PF06482
(Endostatin) 		4 ARG A  62
PHE A 178
PRO A   8
LEU A  10
 None
 1.49A 3tgvC-1bnlA:
0.0		 3tgvC-1bnlA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1cp9 PENICILLIN G AMIDASE
PENICILLIN G AMIDASE

(Providencia
rettgeri;
Providencia
rettgeri) 		PF01804
(Penicil_amidase)
PF01804
(Penicil_amidase) 		4 ARG A 143
TYR B  31
PHE B  50
PRO B  49
 None
 1.46A 3tgvC-1cp9A:
0.0		 3tgvC-1cp9A:
19.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1f3u TRANSCRIPTION
INITIATION FACTOR
IIF, BETA SUBUNIT
TRANSCRIPTION
INITIATION FACTOR
IIF, ALPHA SUBUNIT

(Homo sapiens;
Homo sapiens) 		PF02270
(TFIIF_beta)
PF05793
(TFIIF_alpha) 		4 ARG B  49
TYR B 144
PHE A  96
LEU A 104
 None
 1.19A 3tgvC-1f3uB:
0.9		 3tgvC-1f3uB:
18.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ile ISOLEUCYL-TRNA
SYNTHETASE

(Thermus
thermophilus) 		PF00133
(tRNA-synt_1)
PF08264
(Anticodon_1) 		4 TYR A 293
PHE A 354
PRO A 353
LEU A 349
 None
 1.41A 3tgvC-1ileA:
0.0		 3tgvC-1ileA:
10.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1js4 ENDO/EXOCELLULASE E4

(Thermobifida
fusca) 		PF00759
(Glyco_hydro_9)
PF00942
(CBM_3) 		4 TYR A 399
PHE A 452
PRO A 454
LEU A 449
 None
 1.18A 3tgvC-1js4A:
0.0		 3tgvC-1js4A:
12.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1obh LEUCYL-TRNA
SYNTHETASE

(Thermus
thermophilus) 		PF00133
(tRNA-synt_1)
PF08264
(Anticodon_1)
PF13603
(tRNA-synt_1_2)
PF14795
(Leucyl-specific) 		4 TYR A 508
PHE A 568
PRO A 567
LEU A 546
 None
 1.37A 3tgvC-1obhA:
0.0		 3tgvC-1obhA:
13.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2a9j BISPHOSPHOGLYCERATE
MUTASE

(Homo sapiens) 		PF00300
(His_Phos_1) 		4 ARG A  21
TYR A 132
PRO A 131
LEU A  98
 None
 1.49A 3tgvC-2a9jA:
undetectable		 3tgvC-2a9jA:
20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fv2 RCD1 REQUIRED FOR
CELL
DIFFERENTIATION1
HOMOLOG

(Homo sapiens) 		PF04078
(Rcd1) 		4 TYR A  58
PHE A 106
PRO A 105
LEU A 103
 None
 1.14A 3tgvC-2fv2A:
undetectable		 3tgvC-2fv2A:
18.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2rau PUTATIVE ESTERASE

(Sulfolobus
solfataricus) 		PF12146
(Hydrolase_4) 		4 ARG A 210
PHE A 240
PRO A 230
LEU A 241
 PG4  A 358 (-3.7A)
PG4  A 358 (-4.5A)
PG4  A 358 (-4.3A)
None
 1.42A 3tgvC-2rauA:
undetectable		 3tgvC-2rauA:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2uy1 CLEAVAGE STIMULATION
FACTOR 77

(Encephalitozoon
cuniculi) 		PF05843
(Suf) 		4 TYR A 330
PHE A 363
PRO A 339
LEU A 364
 None
 1.49A 3tgvC-2uy1A:
undetectable		 3tgvC-2uy1A:
14.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vqr PUTATIVE SULFATASE

(Rhizobium
leguminosarum) 		PF00884
(Sulfatase)
PF16347
(DUF4976) 		4 ARG A 407
PHE A 397
PRO A 403
LEU A 394
 None
 1.45A 3tgvC-2vqrA:
undetectable		 3tgvC-2vqrA:
14.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w8s PHOSPHONATE
MONOESTER HYDROLASE

(Paraburkholderia
caryophylli) 		PF00884
(Sulfatase)
PF16347
(DUF4976) 		4 ARG A 407
PHE A 397
PRO A 403
LEU A 394
 SO4  A1517 (-4.4A)
None
None
None
 1.38A 3tgvC-2w8sA:
undetectable		 3tgvC-2w8sA:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3f1z PUTATIVE NUCLEIC
ACID-BINDING
LIPOPROTEIN

(Klebsiella
pneumoniae) 		PF12869
(tRNA_anti-like) 		4 TYR A  68
PHE A  57
PRO A  56
LEU A  54
 None
 1.24A 3tgvC-3f1zA:
undetectable		 3tgvC-3f1zA:
23.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h1v GLUCOKINASE

(Homo sapiens) 		PF00349
(Hexokinase_1)
PF03727
(Hexokinase_2) 		4 ARG X 308
TYR X 273
PHE X  23
LEU X  20
 None
 1.33A 3tgvC-3h1vX:
undetectable		 3tgvC-3h1vX:
14.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hlk ACYL-COENZYME A
THIOESTERASE 2,
MITOCHONDRIAL

(Homo sapiens) 		PF04775
(Bile_Hydr_Trans)
PF08840
(BAAT_C) 		4 ARG A 158
TYR A 235
PHE A 429
LEU A 155
 None
 1.47A 3tgvC-3hlkA:
undetectable		 3tgvC-3hlkA:
16.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3iay DNA POLYMERASE DELTA
CATALYTIC SUBUNIT

(Saccharomyces
cerevisiae) 		PF00136
(DNA_pol_B)
PF03104
(DNA_pol_B_exo1) 		4 TYR A 249
PHE A 213
PRO A 163
LEU A 211
 None
 1.25A 3tgvC-3iayA:
undetectable		 3tgvC-3iayA:
11.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k70 EXODEOXYRIBONUCLEASE
V ALPHA CHAIN

(Escherichia
coli) 		PF13538
(UvrD_C_2)
PF13604
(AAA_30) 		4 ARG D 557
PHE D 449
PRO D 448
LEU D 444
 None
 0.85A 3tgvC-3k70D:
undetectable		 3tgvC-3k70D:
13.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3kx6 FRUCTOSE-BISPHOSPHAT
E ALDOLASE

(Babesia bovis) 		PF00274
(Glycolytic) 		4 ARG A 257
TYR A 356
PHE A 249
LEU A 250
 None
 1.35A 3tgvC-3kx6A:
undetectable		 3tgvC-3kx6A:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3naf CALCIUM-ACTIVATED
POTASSIUM CHANNEL
SUBUNIT
ALPHA-1,CALCIUM-ACTI
VATED POTASSIUM
CHANNEL SUBUNIT
ALPHA-1,CALCIUM-ACTI
VATED POTASSIUM
CHANNEL SUBUNIT
ALPHA-1

(Homo sapiens) 		PF03493
(BK_channel_a) 		4 TYR A1007
PHE A 987
PRO A 986
LEU A 980
 None
 1.46A 3tgvC-3nafA:
undetectable		 3tgvC-3nafA:
11.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3o9p PERIPLASMIC MUREIN
PEPTIDE-BINDING
PROTEIN

(Escherichia
coli) 		PF00496
(SBP_bac_5) 		4 TYR A 272
PHE A 315
PRO A 479
LEU A 471
 None
 1.45A 3tgvC-3o9pA:
undetectable		 3tgvC-3o9pA:
14.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pqv RCL1 PROTEIN

(Kluyveromyces
lactis) 		PF01137
(RTC)
PF05189
(RTC_insert) 		4 TYR A 298
PHE A 108
PRO A 107
LEU A 105
 None
 1.25A 3tgvC-3pqvA:
undetectable		 3tgvC-3pqvA:
17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pxp HELIX-TURN-HELIX
DOMAIN PROTEIN

(Chloroflexus
aurantiacus) 		PF13560
(HTH_31) 		4 TYR A 239
PHE A 269
PRO A 110
LEU A 268
 None
 1.45A 3tgvC-3pxpA:
undetectable		 3tgvC-3pxpA:
20.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tgv HEME-BINDING PROTEIN
HUTZ

(Vibrio cholerae) 		PF01243
(Putative_PNPOx) 		5 ARG A  22
TYR A  53
PHE A  95
PRO A 140
LEU A 144
 None
 0.23A 3tgvC-3tgvA:
27.8		 3tgvC-3tgvA:
100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3win 17 KD HEMAGGLUTININ
COMPONENT

(Clostridium
botulinum) 		PF05588
(Botulinum_HA-17) 		4 ARG C  54
PHE C  88
PRO C  89
LEU C 102
 None
 1.28A 3tgvC-3winC:
undetectable		 3tgvC-3winC:
17.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4cv5 PROTEIN CAF40

(Saccharomyces
cerevisiae) 		PF04078
(Rcd1) 		4 TYR B 160
PHE B 208
PRO B 207
LEU B 205
 None
 1.23A 3tgvC-4cv5B:
undetectable		 3tgvC-4cv5B:
18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4etz PELD

(Pseudomonas
aeruginosa) 		PF13492
(GAF_3)
PF16963
(PelD_GGDEF) 		4 ARG A 168
TYR A 327
PRO A 389
LEU A 164
 None
 1.25A 3tgvC-4etzA:
undetectable		 3tgvC-4etzA:
19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f92 U5 SMALL NUCLEAR
RIBONUCLEOPROTEIN
200 KDA HELICASE

(Homo sapiens) 		PF00270
(DEAD)
PF00271
(Helicase_C)
PF02889
(Sec63) 		4 TYR B1266
PHE B1286
PRO B1263
LEU B1289
 None
 1.43A 3tgvC-4f92B:
undetectable		 3tgvC-4f92B:
6.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4j2g KLTH0A00704P

(Lachancea
thermotolerans) 		PF10033
(ATG13) 		4 ARG A 232
TYR A 250
PRO A 166
LEU A 164
 None
 1.06A 3tgvC-4j2gA:
undetectable		 3tgvC-4j2gA:
18.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pfw ABC TRANSPORTER
SUBSTRATE-BINDING
PROTEIN

(Thermotoga
maritima) 		PF00496
(SBP_bac_5) 		4 TYR A 287
PHE A 360
PRO A 372
LEU A 358
 None
 1.11A 3tgvC-4pfwA:
undetectable		 3tgvC-4pfwA:
13.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pfy ABC TRANSPORTER
SUBSTRATE-BINDING
PROTEIN

(Thermotoga
maritima) 		PF00496
(SBP_bac_5) 		4 TYR A 287
PHE A 360
PRO A 372
LEU A 358
 None
 1.14A 3tgvC-4pfyA:
undetectable		 3tgvC-4pfyA:
13.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ph9 PROSTAGLANDIN G/H
SYNTHASE 2

(Mus musculus) 		PF00008
(EGF)
PF03098
(An_peroxidase) 		4 ARG A 470
PHE A 530
PRO A 529
LEU A 526
 None
 1.47A 3tgvC-4ph9A:
undetectable		 3tgvC-4ph9A:
12.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4rs2 PREDICTED
ACYLTRANSFERASE WITH
ACYL-COA
N-ACYLTRANSFERASE
DOMAIN

(Escherichia
coli) 		PF13508
(Acetyltransf_7) 		4 ARG A  35
TYR A  56
PRO A  76
LEU A  34
 None
 1.39A 3tgvC-4rs2A:
undetectable		 3tgvC-4rs2A:
21.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uph SULFATASE (SULFURIC
ESTER HYDROLASE)
PROTEIN

(Agrobacterium
tumefaciens) 		PF00884
(Sulfatase)
PF16347
(DUF4976) 		4 ARG A 411
PHE A 401
PRO A 407
LEU A 398
 None
 1.32A 3tgvC-4uphA:
undetectable		 3tgvC-4uphA:
13.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4upk PHOSPHONATE
MONOESTER HYDROLASE

(Ruegeria
pomeroyi) 		PF00884
(Sulfatase) 		4 ARG A 399
PHE A 389
PRO A 395
LEU A 386
 None
 1.33A 3tgvC-4upkA:
undetectable		 3tgvC-4upkA:
13.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4uyb SEC14-LIKE PROTEIN 3

(Homo sapiens) 		PF00650
(CRAL_TRIO) 		4 TYR A 100
PHE A 241
PRO A 238
LEU A 228
 None
 1.41A 3tgvC-4uybA:
undetectable		 3tgvC-4uybA:
15.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4w8y CRISPR SYSTEM CMR
SUBUNIT CMR2

(Pyrococcus
furiosus) 		PF12469
(DUF3692) 		4 TYR A 100
PHE A  73
PRO A  87
LEU A  20
 None
 1.34A 3tgvC-4w8yA:
undetectable		 3tgvC-4w8yA:
9.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4zwn MONOGLYCERIDE LIPASE

(Saccharomyces
cerevisiae) 		PF12146
(Hydrolase_4) 		4 TYR A   4
PHE A 198
PRO A   5
LEU A 199
 None
 1.38A 3tgvC-4zwnA:
undetectable		 3tgvC-4zwnA:
16.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5gy0 GLUCANASE

(Ruminiclostridium
thermocellum) 		PF00759
(Glyco_hydro_9)
PF00942
(CBM_3) 		4 TYR A 411
PHE A 463
PRO A 465
LEU A 460
 None
None
CL  A 705 ( 4.2A)
CL  A 705 (-3.7A)
 1.32A 3tgvC-5gy0A:
undetectable		 3tgvC-5gy0A:
13.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lc5 NADH-UBIQUINONE
OXIDOREDUCTASE CHAIN
4

(Bos taurus) 		PF00361
(Proton_antipo_M)
PF01059
(Oxidored_q5_N) 		4 ARG M 245
TYR M 241
PHE M 118
LEU M 115
 None
 1.34A 3tgvC-5lc5M:
undetectable		 3tgvC-5lc5M:
17.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lm8 'MULTICOPPER OXIDASE

(Aspergillus
niger) 		PF00394
(Cu-oxidase)
PF07731
(Cu-oxidase_2)
PF07732
(Cu-oxidase_3) 		4 ARG A 482
TYR A 291
PHE A 354
PRO A 284
 None
 1.29A 3tgvC-5lm8A:
undetectable		 3tgvC-5lm8A:
15.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5lw7 ABC TRANSPORTER
ATP-BINDING PROTEIN

(Pyrococcus
abyssi) 		PF00005
(ABC_tran)
PF00037
(Fer4)
PF04068
(RLI) 		4 TYR B 153
PHE B 235
PRO B 164
LEU B 268
 None
 1.46A 3tgvC-5lw7B:
undetectable		 3tgvC-5lw7B:
12.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nqf APICAL MEMBRANE
ANTIGEN 1

(Plasmodium
falciparum) 		PF02430
(AMA-1) 		4 TYR A 117
PHE A 312
PRO A 416
LEU A 419
 TYR  A 117 ( 1.3A)
PHE  A 312 ( 1.3A)
PRO  A 416 ( 1.1A)
LEU  A 419 ( 0.5A)
 1.48A 3tgvC-5nqfA:
undetectable		 3tgvC-5nqfA:
16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5okd CYTOCHROME B-C1
COMPLEX SUBUNIT
RIESKE,
MITOCHONDRIAL

(Bos taurus) 		no annotation 4 ARG E  99
PHE E  97
PRO E 146
LEU E 135
 None
 1.39A 3tgvC-5okdE:
undetectable		 3tgvC-5okdE:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5td7 ZGC:55652

(Danio rerio) 		PF00850
(Hist_deacetyl) 		4 TYR A 574
PHE A 245
PRO A 571
LEU A 249
 None
 1.42A 3tgvC-5td7A:
undetectable		 3tgvC-5td7A:
12.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wzr ALPHA-N-ACETYLGALACT
OSAMINIDASE

(Bifidobacterium
bifidum) 		PF11308
(Glyco_hydro_129) 		4 ARG A 507
TYR A 541
PHE A 621
LEU A 605
 None
 1.34A 3tgvC-5wzrA:
undetectable		 3tgvC-5wzrA:
13.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5y3t E3 UBIQUITIN-PROTEIN
LIGASE RNF31

(Mus musculus) 		no annotation 4 ARG B 610
PHE B 614
PRO B 613
LEU B 611
 None
 1.41A 3tgvC-5y3tB:
undetectable		 3tgvC-5y3tB:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6b4m MONOTREME LACTATION
PROTEIN

(Ornithorhynchus
anatinus) 		no annotation 4 ARG A 231
TYR A 169
PHE A  56
PRO A 162
 None
 1.34A 3tgvC-6b4mA:
undetectable		 3tgvC-6b4mA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6g45 PUTATIVE MAJOR
CAPSID PROTEIN

(Cafeteriavirus-dependent
mavirus) 		no annotation 4 TYR A 284
PHE A 218
PRO A 206
LEU A 221
 None
 1.48A 3tgvC-6g45A:
undetectable		 3tgvC-6g45A:
undetectable